English

ANGIOGENEX, INC.

EDGAR

Quarterly report (10-Q) · filed 2019-08-14

63 filing records in this dataset, filed from 1999-07-27 to 2019-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-3.83 thousand USD

2009-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -68093 USD Source
Operating Cash Flow: -64267 USD Source

Free cash flow

-3.83 thousand USD

2009-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -68093 USD Source
Operating Cash Flow: -64267 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 117 thousand USD 2018-09-30 Source
Exact value

117341 USD
Long-term debt including current maturities: Not available
Shares outstanding: 30.4 million shares 2019-06-30 Source
Exact value

30386667 shares

Reported share-count change

3.40% · 1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

29386667 shares · 2018-06-30· Source
30386667 shares · 2019-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Revenue: 0 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 0 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 0 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 0 USD · 2009-04-01 – 2009-06-30 Source
Revenue: 0 USD · 2009-07-01 – 2009-09-30 Source

Net income

-893 thousand USD

2018-07-01 – 2019-06-30

Exact inputs and evidence

Net income: -80631 USD · 2018-07-01 – 2018-09-30 Source
Net income: -435448 USD · 2018-01-01 – 2018-12-31 Source
Net income: -349781 USD · 2018-01-01 – 2018-09-30 Source
Net income: -579279 USD · 2019-01-01 – 2019-03-31 Source
Net income: -147383 USD · 2019-04-01 – 2019-06-30 Source

Operating cash flow

-399 thousand USD

2018-07-01 – 2019-06-30

Exact inputs and evidence

Operating cash flow: -361219 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -232294 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -453789 USD · 2018-01-01 – 2018-12-31 Source
Operating cash flow: -361219 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -116284 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -177571 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -116284 USD · 2019-01-01 – 2019-03-31 Source

Capital expenditure

0 USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-08-14.

Financial data available through: 2018-12-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2008-12-31
Operating income: 4 of 11 periods available· newest 2018-12-31
Net income: 4 of 11 periods available· newest 2018-12-31
Operating cash flow: 4 of 11 periods available· newest 2018-12-31
Capital expenditure: 1 of 11 periods available· newest 2008-12-31
Total assets: 4 of 11 periods available· newest 2018-12-31
Total liabilities: 2 of 11 periods available· newest 2018-12-31
Current assets: 4 of 11 periods available· newest 2018-12-31
Current liabilities: 4 of 11 periods available· newest 2018-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2017-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2018-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 247,581

Prior period

−USD 683,029

2017-01-01 – 2017-12-31
Current period

−USD 435,448

2018-01-01 – 2018-12-31

Exact inputs and evidence

-435448 − -683029 = 247581 USD

-683029 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-435448 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ANGIOGENEX, INC. · 2018-12-31 ANGIOGENEX, INC. (edgar:1085596) Year-over-year change in Net income: 247581 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -435448 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#40084 Filing: 000146970919000043 Input fundies:NetIncome: -683029 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#39801 Filing: 000146970919000043
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 75,006

Prior period

−USD 528,795

2017-01-01 – 2017-12-31
Current period

−USD 453,789

2018-01-01 – 2018-12-31

Exact inputs and evidence

-453789 − -528795 = 75006 USD

-528795 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-453789 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ANGIOGENEX, INC. · 2018-12-31 ANGIOGENEX, INC. (edgar:1085596) Year-over-year change in Operating cash flow: 75006 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -453789 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#60297 Filing: 000146970919000043 Input fundies:OperatingCashFlow: -528795 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#60113 Filing: 000146970919000043
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 0
Operating costs Derived USD 390,768
Operating income −USD 390,768
Tax, interest and other Derived USD 9,995
Net income −USD 400,763

Cash

Operating cash flow −USD 136,263
Capital expenditure USD 0
Free cash flow Derived −USD 136,263

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	0	390768 Derived	-390768	9995 Derived	-400763	-136263 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -390768 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -400763 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -136263 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	Not reported	Operating Income: -390768 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -400763 Open source Revenue: 0 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -136263 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -136.3K 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-136263	Operating Cash Flow: -136263 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -136.3K 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-136263	Operating Cash Flow: -136263 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	Total Assets: 12990 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	0.02×	Current Assets: 12421 Open source Current Liabilities: 617417 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 400,763 Exact value Exact value: -400763 USD 2008-01-01 – 2008-12-31: -400763 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOGENEX, INC. · 2008-12-31 ANGIOGENEX, INC. (edgar:1085596) Net Income: -400763 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -400763 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/0001449388-09-000048.txt#11133 The citation records this snapshot. The page link may show a newer release later.	−USD 136,263 Exact value Exact value: -136263 USD 2008-01-01 – 2008-12-31: -136263 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOGENEX, INC. · 2008-12-31 ANGIOGENEX, INC. (edgar:1085596) Operating Cash Flow: -136263 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -136263 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/0001449388-09-000048.txt#11637 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOGENEX, INC. · 2008-12-31 ANGIOGENEX, INC. (edgar:1085596) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/0001449388-09-000048.txt#11720 The citation records this snapshot. The page link may show a newer release later.	−USD 136,263 Calculation and evidence -136263 − 0 USD Exact free cash flow: -136263 USD 2008-01-01 – 2008-12-31: -136263 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOGENEX, INC. · 2008-12-31 ANGIOGENEX, INC. (edgar:1085596) Free cash flow: -136263 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -136263 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/0001449388-09-000048.txt#11637 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/0001449388-09-000048.txt#11720 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 448,527 Exact value Exact value: -448527 USD 2016-01-01 – 2016-12-31: -448527 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOGENEX, INC. · 2016-12-31 ANGIOGENEX, INC. (edgar:1085596) Net Income: -448527 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -448527 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970918000055/aggx-20171231.xml#27383 Filing: 000146970918000055 The citation records this snapshot. The page link may show a newer release later.	−USD 83,415 Exact value Exact value: -83415 USD 2016-01-01 – 2016-12-31: -83415 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOGENEX, INC. · 2016-12-31 ANGIOGENEX, INC. (edgar:1085596) Operating Cash Flow: -83415 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -83415 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970918000055/aggx-20171231.xml#31560 Filing: 000146970918000055 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 683,029 Exact value Exact value: -683029 USD 2017-01-01 – 2017-12-31: -683029 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOGENEX, INC. · 2017-12-31 ANGIOGENEX, INC. (edgar:1085596) Net Income: -683029 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -683029 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#39801 Filing: 000146970919000043 The citation records this snapshot. The page link may show a newer release later.	−USD 528,795 Exact value Exact value: -528795 USD 2017-01-01 – 2017-12-31: -528795 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOGENEX, INC. · 2017-12-31 ANGIOGENEX, INC. (edgar:1085596) Operating Cash Flow: -528795 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -528795 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#60113 Filing: 000146970919000043 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 435,448 Exact value Exact value: -435448 USD 2018-01-01 – 2018-12-31: -435448 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOGENEX, INC. · 2018-12-31 ANGIOGENEX, INC. (edgar:1085596) Net Income: -435448 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -435448 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#40084 Filing: 000146970919000043 The citation records this snapshot. The page link may show a newer release later.	−USD 453,789 Exact value Exact value: -453789 USD 2018-01-01 – 2018-12-31: -453789 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOGENEX, INC. · 2018-12-31 ANGIOGENEX, INC. (edgar:1085596) Operating Cash Flow: -453789 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:47:03Z Snapshot: e3268bef22e21f446c26437f195a975ab7285d59704228dfdf46297303902982 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1085596/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -453789 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000043/aggx-20181231.xml#60297 Filing: 000146970919000043 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 371 latest values · 371 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001085596, 1085596, edgar:1085596

Also known as ANGIOGENEX, INC., AngioGenex, Inc., ECLIC INC/NV

ANGIOGENEX, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation